a Jouhou Koukai business



Primary Market Research
Pharmaceuticals, Medical Devices and Healthcare in Japan


Licenscape is a dedicated provider of primary market research services in Japan with focus on prescription medicinal products regulated in Japan by the Ministry of Health, Labor and Welfare. Covered is the entire market research process from obtaining to analyzing the physicians opinions on issues related to the development new pharmaceuticals and medical devices, therapeutic options and unmet needs, and introduction of new products under competitive conditions.



Physicians are recruited by the following criteria:

  • from national universities hospitals, major private universities hospitals, metropolitan hospitals, community-based GP, regional hospitals, individual practitioners
  • from major metropolitan areas (Tokyo, Osaka, Sendai, Fukuoka, Sapporo) and the adjacent prefectures
  • from endemic regions 
  • KOLs
  • internationally recognized medical specialties

Recruited physicians lists are available for prescreening by the sponsors.


Physicians and other interviewees are subjected to in-depth face-to-face interviews by trained fields interviewers. Complete digital audio or video records of interviews, transcripts in Japanese, translation of the transcripts to English are provided. 

Support and advisory: re-design of the questionnaires to fit the Japanese practice, translation and verification.

Content analysis

Summary of principle findings, quantitative and qualitative analysis, interpretation.

Pricing sensitivity, competitors lock-up, cultural acceptance of new products.

Secondary research

  • Market segmentation, sentience, trends, customs
  • Patients populations - prevalent morbidity, unmet medical needs, orphan designations
  • Products - regulatory approvals, documents, requirements under the Japanese regulations
  • Profiles of the registered pharmaceutical manufacturers in Japan
  • Restructured portfolios, patented pharmaceuticals, generics, prescription and proprietary medicines, switches, orphan drugs

Key disease/therapeutic expertise

Representative studies on clinically and commercially significant diseases.

Inquiries | Contact | Confidentiality

  • Physicians 
  • Patients
  • Nurses
  • Patients families
  • Healthcare personnel
  • Pharmacists
  • Wholesalers
  • Reimbursement officials
  • Full bilingual support
  • All document formats
  • Electronic delivery
  • Regulatory support
  • Logistics

Findings from recent research

Genital Herpes in Japan

  • 65-75% of patients with GH are females
  • A female patient would bring her male partner to a gynecologist of general practice for simultaneous treatment
  • Treatment for both the episodes of the primary outbreak and recurrences is reimbursable

Copyright 2001-2022. All rights reserved worldwide. All materials on this web site are protected by copyrights.